Apatinib-based targeted therapy against pulmonary sarcomatoid carcinoma: a case report and literature review

Sarcomatoid carcinoma is a rare malignancy characterized by a combination of epithelial and sarcoma or sarcoma-like components. In this study, we reported one case of pulmonary sarcomatoid carcinoma and evaluated the safety and efficacy of apatinib, a tyrosine kinase inhibitor selectively targeting...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaofeng, He, Yueming, Zhu, Jinfeng, Pang, Hongxia, Lin, Yongwei, Zheng, Jinyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154744/
https://www.ncbi.nlm.nih.gov/pubmed/30263099
http://dx.doi.org/10.18632/oncotarget.25989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154744/
https://www.ncbi.nlm.nih.gov/pubmed/30263099
http://dx.doi.org/10.18632/oncotarget.25989

Ejemplares similares